HomeInsightsPB

Zydus Lifesciences Ltd PB Ratio

Zydus Lifesciences Ltd PB Ratio

stocks purchased

₹ 0.8 Cr

Volume Transacted

(Nov 8, 2024)

stocks purchased

7.9 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 08, 2024

Image

Zydus Lifesciences Ltd

NSE: ZYDUSLIFE

PB

4.9

Last updated on: Nov 07, 2024

Key Highlights

  • The P/B Ratio of Zydus Lifesciences Ltd is 4.9 as of 07 Nov 24.
  • The P/B Ratio of Zydus Lifesciences Ltd changed from 2.1 on March 2022 to 5.1 on March 2024 . This represents a CAGR of 34.42% over 3 years. .

Historical P/B Ratio of Zydus Lifesciences Ltd

No data available

Company Fundamentals for Zydus Lifesciences Ltd

Market Cap

97,866 Cr

EPS

41.4

P/E Ratio (TTM) *

23.5

P/B Ratio (TTM) *

4.9

Day’s High *

980.85

Day’s Low

968.85

DTE *

0.0

ROE *

19.5

52 Week High

1323.9

52 Week Low

598.05

ROCE *

22.7

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Zydus Lifesciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 2024972.6
06 Nov 2024995
05 Nov 2024989.3
04 Nov 20241004.3
01 Nov 20241004
31 Oct 20241001.85
30 Oct 2024985.55
29 Oct 20241002.3
28 Oct 20241006.65
25 Oct 2024990.2

SWOT Analysis Of Zydus Lifesciences Ltd

Strength

3

S

Weakness

3

W

Opportunity

0

O

Threats

2

T

BlinkX Score for Zydus Lifesciences Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Zydus Lifesciences Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/B Ratio

Company NamePBMarket Cap (INR Cr.)
Zydus Lifesciences Ltd497,866
Sun Pharmaceuticals Industries Ltd984,29,841
Divis Laboratories Ltd5071,58,179
Cipla Ltd3601,27,063
Mankind Pharma Ltd2691,09,234
Dr Reddys Laboratories Ltd3221,07,398

Key Valuation Metric of Zydus Lifesciences Ltd

Share Price

₹977

PB Ratio

The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share.


How to calculate Price-to-Book (P/B) Ratio?

The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company.


Market capitalization = market value of a stock X no. of outstanding shares


Now, you need to know the net value of an organization's assets.

Book Value of Assets = Total Assets - Total Liabilities of a company


After knowing the value of the above ratios, here is the formula for the P/B Ratio:

P/B Ratio = Market Capitalization/ Book Value of Assets


or you can also use this formula

P/B ratio = Market Price Per Share/ Book Value of Asset Per Share

Historical Market Cap of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical Revenue of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical EBITDA of Zydus Lifesciences Ltd

No data available

* All values are in crore

Historical Net Profit of Zydus Lifesciences Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Zydus Lifesciences Ltd News Hub

News

Zydus Lifesciences to table results

Zydus Lifesciences will hold a meeting of the Board of Directors of the Company on 12 Nove...

Read more

31 Oct 202411:58

News

Zydus Life rises on in-principle approval from WHO for typhoid vaccine

ZyVac TCV is now eligible for purchase by United Nations (UN) agencies. It is indigenously...

Read more

23 Oct 202414:50

News

Zydus receives USFDA approval for Fludrocortisone Acetate Tablets

Zydus Lifesciences has received final approval from the United States Food and Drug Admini...

Read more

18 Oct 202409:29

News

Zydus Life gets final approval from USFDA for Fludrocortisone Acetate tab

Fludrocortisone Acetate tablets are indicated as partial replacement therapy for primary a...

Read more

18 Oct 202412:47

News

Zydus partners with ICMR to initiate Phase 2 clinical trials of Desidustat oral tablet for treating sickle cell disease

Zydus Lifesciences has formalized the Memorandum of Agreement (MoA) with Indian Council of...

Read more

15 Oct 202410:08

News

Zydus Life gets final approval from USFDA for Paliperidone drug

Paliperidone extended-release tablets are indicated for the acute and maintenance treatmen...

Read more

10 Oct 202414:51

Document

Annual Reports

Annual Report 2024

dropdown
download

Credit Ratings

Credit Report 2024

dropdown
download

Concalls

Sep 2021

Transcript

Jan 2021

PPT

Aug 2020

PPT

Feb 2020

PPT

FAQs for PB Ratio of Zydus Lifesciences Ltd

What is the PB ratio of Zydus Lifesciences Ltd?

The current PB ratio of Zydus Lifesciences Ltd is 4.94. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Zydus Lifesciences Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Zydus Lifesciences Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Zydus Lifesciences Ltd calculated?

The PB ratio of Zydus Lifesciences Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Zydus Lifesciences Ltd?

A high PB ratio suggests that Zydus Lifesciences Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Zydus Lifesciences Ltd?

A low PB ratio of Zydus Lifesciences Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Zydus Lifesciences Ltd PB Ratio change over time?

Yes, the PB ratio of Zydus Lifesciences Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*